Summary
Increasing use of immunocytochemistry for evaluation of dementia disorders has revealed histopathological alterations that were previously unknown, even with sensitive silver techniques. Disorders [Pick’s disease (PD), diffuse Lewy body disease (DLBD) and corticobasal degeneration (CBD)] in which immunocytochemistry has revealed occult pathology are discussed. All three disorders have neurofilament (NF) immunoreactive neuronal alterations in the neocortex. In DLBD round, eosinophilic cytoplasmic inclusions referred to as cortical Lewy bodies are neurofilament-positive, while in both PD and CBD neurofilament epitopes are expressed in irregularly swollen neurons and their proximal cell processes, which are referred to as ballooned neurons. Interestingly, the cortical neuronal population that is vulnerable to Lewy bodies is similar to that which is vulnerable to ballooned neurons. Furthermore, Lewy bodies can occasionally be detected within the cytoplasm of ballooned neurons. Besides neurofilament-immunoreactivity, Lewy bodies are immunoreactive for ubiquitin, while ballooned neurons are inconsistently stained with antibodies to ubiquitin. Both Lewy bodies and ballooned neurons can be appreciated with routine histology, but they are much easier to detect with immunocytochemistry. In contrast, a new type of neuritic alteration in the hippocampal CA2/3 region has been recognized in DLBD. These dystrophic neurites cannot be appreciated with routine histology and are only optimally seen with immunocytochemistry for ubiquitin. Their presence is a certain indication of the presence of cortical Lewy bodies.
The microtuble associated protein tau is the major constituent of neurofibrillary tangles in Alzheimer’s disease (AD). Biochemical studies have shown that Pick bodies, argyrophilic neuronal inclusions that are highly characteristic of, if not pathognomonic for PD are also composed of abnormal tau protein. Along with Pick bodies, tau has recently been detected in glial cells in PD. Similar so-called “gliofibrillary tangles” are increasingly recognized in progressive supranuclear palsy. Previously, CBD was considered to be free of such lesions, but recent studies have revealed widespread tau-positive neuronal and glial cytoskeletal lesions in CBD. A distinctive type of tau-positive glial lesion in CBD is characterized by annular clusters of grain-like tau immunoreactivity reminiscent of a neuritic plaque in AD, except that the clusters are devoid of amyloid. The tau-positive profiles are consistently located around a central astrocyte cell body. Double labeling studies with glial fibrillary acidic protein, vimentin and CD44, which are markers for reactive astrocytes, demonstrates tau immunoreactivity within astrocytic processes; these “astrocytic plaques” appear to be specific for CBD. Although NF, ubiquitin and tau proteins are present in diverse neuronal and glial inclusions in these disorders, the morphology and distribution of these lesions differentiate non-AD dementias.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe H, Yagishita S, Amano N, Iwabuchi D, Hasegawa K, Kowa K (1992) Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy immunocytochemical and ultrastructural study. Acta Neuropathol 84: 273–277
Ball MJ (1979) Topography of Pick inclusion bodies in hippocampi of demented patients. A quantiative study. J Neuropathol Exp Neurol 38: 614–620
Binder LI, Frankfurter A, Rebum LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371–1378
Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65: 351–355
Braak H, Braak E (1987) Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 76: 124–127
Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol 88: 493–500
Clark AW, Manz HJ, White CL 3d, Lehmann J, Miller D, Coyle JT (1986) Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick’s disease. J Neuropathol Exp Neurol 45: 268–284
Crystal HA, Dickson DW, Sliwinski M, Lipton R, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34: 566–573
Davis DG, Wang HZ, Markesbery WR (1992) Image analysis of neuropil threads in Alzheimer’s, Pick’s, diffuse Lewy body disease and in progressive supranuclear palsy. J Neuropathol Exp Neurol 51: 594–600
Dickson DW, Wu E, Crystal HA, Mattiace LA, Yen S-HC, Davies P (1992) Alzheimer and age-related pathology in diffuse Lewy body disease. In: Boller F, Forcette F, Khachaturian Z, Poncet M, Christen Y (eds) Heterogeneity of Alzheimer’s disease. Springer, Berlin Heidelberg New York Tokyo, pp 168–186
Dickson DW, Yen S-H (1994) Ubiquitin, the cytoskeleton and neurodegenerative disease. In: Mayer RJ, Brown IR (eds) Heat shock or stress proteins and the nervous system. Academic Press, London, pp 235–264
Dickson DW, Ksiezak-Reding H, Liu W-K, Davies P, Crowe A, Yen S-HC (1992) Immunocytochemistry of neurofibrillary tangles (NFT) with antibodies to subregions of tau protein: identification of hidden and cleaved epitopes and a new phosphorylation site. Acta Neuropathol 84: 596–605
Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-H (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41: 1402–1409
Dickson DW, Schmidt ML, Lee VM-Y, Trojanowski JQ, Yen S-H (1994) Hippocampal neurites in diffuse Lewy body disease• immunocytochemical characterization and local origin Acta Neuropathol 87: 269–276
Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H (1990) Ubiquitin-immunoreactive structures in normal brains: distribution and developmental aspects. Lab Invest 63: 87–99
Dickson DW, Yen S-H, Suzuki KI, Davies P, Garcia JH, Hirano A (1986) Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol 71: 216–223
Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388–1396
Feany MB, Ksiezak-Reding H, Liu W-K, Vincent I, Yen S-HC, Dickson DW (1995) Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 90: 37–43
Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease, and corticobasal degeneration. J Neuropathol Exp Neurol 55: 53–67
Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–466
Geddes JF, Hughes AJ, Lees AJ, Daniel SE (1993) Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain 116: 281–302
Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171–1192
Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol 1: 279–286
Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87: 5827–5831
Hauw J-J, Daniel SE, Dickson DW, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for SteeleRichardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015–2019
Horoupian DS, Chu PL (1994) Unusual case of corticobasal degeneration with tau/ Gallyas-positive neuronal and glial tangles. Acta Neuropathol 88: 592–598
Ihara Y, Nukina N, Miura R, Ogawara M (1988) Phosphorylated tau protein is integrated in paired helical filaments in Alzheimer disease. J Biochem 99: 1807–1810
Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T (1994) Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 174: 157–159
Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T (1989) Identification and localization of tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 86: 5646–5650
Iwatsubo T, Hasegawa M, Ihara Y (1994) Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 88: 129–136
Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 3: 185–192
Kowall NW, Kosik KS (1987) Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer’s disease. Ann Neurol 22: 639–643
Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu W-K, Yen S-H, Weidenheim KM, Dickson DW (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145: 1–14
Lee VM-Y, Balin B, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 451: 675–678
Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47: 393–405
Lowe J, Errington DR, Lennox G, Pike I, Spendlove I, Landon M, Mayer RJ (1992) Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin. Neuropathol Appl Neurobiol 18: 341–350
Mochizuki A, Mizusawa H, Ohkoshi N, Yoshizawa K, Komatsuzaki Y, Inoue K, Kanazawa I (1992) Argentophilic intracytoplasmic inclusions in multiple system atrophy. J Neurol 239: 311–316
Mori H, Nishimura M, Namba Y, Oda M (1994) Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 88: 113–121
Murayama S, Arima K, Nakazato Y, Satoh J, Oda M, Inose T (1992) Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions. Acta Neuropathol 84: 32–38
Murayama S, Mori H, Ihara Y, Tomonaga M (1990) Immunocytochemical and ultrastructural studies of Pick’s disease. Ann Neurol 27: 394–405
Nishimura M, Namba Y, Ideda K, Oda M (1992) Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranculear palsy. Neurosci Lett 143: 35–38
Papp MI, Kohn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy and Shy-Drager syndrome. J Neurol Sci 94: 79–100
Pollanen MS, Dickson DW, Bergeron C (1993). Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183–191
Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy: a heterogenous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–339
Tabaton M, Mandybur TI, Perry G, Onorato M, Autillo-Gambetti L, Gambetti P (1989) The widespread alteration of neufites in Alzheimer’s disease may be unrelated to amyloid deposition. Ann Neurol 26: 771–778
Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Honna A, Honna Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87: 545–553
Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, taupositive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 35: 99–102
Yamazaki M, Nakano I, Imazu O, Kaieda R, Terashi A (1994) Astrocytic straight tubules in the brain of a patient with Pick’s disease. Acta Neuropathol 88: 587–591
Yen S-H, Dickson DW, Peterson C, Goldman JE (1986) Cytoskeletal abnormalities in neuropathology. In: Zimmerman HM (ed) Progress in neuropathology, vol 6. Raven Press, New York, pp 63–90
Yen S-H, Liu W-K, Hall FL, Yan S-D, Stern D, Dickson DW (1995) Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiol Aging 16: 381–387
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag
About this paper
Cite this paper
Dickson, D.W., Feany, M.B., Yen, SH., Mattiace, L.A., Davies, P. (1996). Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal Degeneration. In: Jellinger, K.A., Windisch, M. (eds) New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia. Journal of Neural Transmission Supplement, vol 47. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6892-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6892-9_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82823-6
Online ISBN: 978-3-7091-6892-9
eBook Packages: Springer Book Archive